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Background: Cross cultural validity is of vital importance for international comparisons.
Objective: To investigate the validity of international Dutch-English comparisons when using the Dutch
translation of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC).
Patients and Methods: The dimensionality, reliability, construct validity, and cross cultural equivalence of
the Dutch WOMAC in Dutch and Canadian patients waiting for primary total hip arthroplasty was
investigated. Unidimensionality and cross cultural equivalence was quantified by principal component and
Rasch analysis. Intratest reliability was quantified with Cronbach’s a, and test-retest reliability with the
intraclass correlation coefficient. Construct validity was quantified by correlating sum scores of the Dutch
WOMAC, Arthritis Impact Measurement Scales (Dutch AIMS2), Health Assessment Questionnaire (Dutch
HAQ), and Harris Hip Score (Dutch HHS).
Results: The WOMAC was completed by 180 Dutch and 244 English speaking Canadian patients.
Unidimensionality of the Dutch WOMAC was confirmed by principal component and Rasch analysis
(good fit for 20/22 items). The intratest reliability of the Dutch WOMAC for pain and physical functioning
was 0.88 and 0.96, whereas the test-retest reliability was 0.77 and 0.92, respectively. Dutch WOMAC
pain sum score correlated 0.69 with Dutch HAQ pain, and 0.39 with Dutch HHS pain. Dutch WOMAC
physical functioning sum score correlated 0.46 with Dutch AIMS2 mobility, 0.62 with Dutch AIMS2
walking and bending, 0.67 with Dutch HAQ disability, and 0.49 with Dutch HHS function. Differential
item functioning (DIF) was shown for 6/22 Dutch items.
Conclusions: The Dutch WOMAC permits valid international Dutch-English comparisons after correction
for DIF.
T
he past 25 years have seen the development of a large
number of health related quality of life (HR QOL)
measurement instruments, and these instruments are
being used increasingly in research, with a growing emphasis
on multinational applications.1 A goal of HR QOL instru-
ments is the use of these instruments cross nationally which
stems, in part, from the need to pool data from multinational
studies.2 In addition, there is increasing international
collaboration in HR QOL research.3
The cross national use of HR QOL instruments has created
a need for cross culturally valid instruments for outcome
assessment.3 Many studies that investigate cross cultural
validity of an HR QOL instrument report on the careful
translation process, and investigate the clinimetric properties
(dimensionality, reliability, and construct validity) of the
translated instrument. This is an approach based on classical
test theory.4 It deals with the issue of whether the items
(questions) from the translated measurement instrument
measure only one (dimensionality), and the same (reliability)
construct that is related to other measures as hypothesised
(construct validity). This approach, however, does not answer
the key question of whether scores on the translated items
can be compared with scores on the original items. For
instance, Dutch patients with the same HR QOL as Canadian
patients, and responding to the Dutch version of an HR QOL
questionnaire should attain the same score as Canadian
patients responding to the English version of the HR QOL
questionnaire. Evaluating different cultural (including lan-
guage) groups (for example, Dutch and English speaking
patients) without significant bias requires a study of cross
cultural equivalence.5 The investigation of cross cultural
equivalence is based on item response theory.4 ‘‘Equivalence’’
in this context refers to the absence of item bias5 or
differential item functioning (DIF).
The Western Ontario and McMaster Universities osteoarth-
ritis index (WOMAC) is increasingly used for international
research in patients with hip osteoarthritis (OA).6 Pain and
physical functioning are among the major determinants of
HR QOL in patients with OA.7 8 The WOMAC measures these
determinants by assessing five pain related activities and 17
functional activities.9 The clinimetric properties of the
original English version of the WOMAC are well known.6 9
An increasing number of translations are available.10–14
Recently, we have made a Dutch translation of the WOMAC.
The purpose of this study was to investigate the dimen-
sionality, reliability, construct validity, and the cross cultural
equivalence of the Dutch translation of the WOMAC in
patients with OA waiting for primary total hip arthroplasty
(THA).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: AIMS, Arthritis Impact Measurement Scale; CI,
confidence interval; DIF, differential item functioning; HAQ, Health
Assessment Questionnaire; HHS, Harris Hip Score; HR QOL, health
related quality of life; ICC, intraclass correlation coefficient; OA,
osteoarthritis; SD, standard deviation; SE, standard error; THA, total hip
arthroplasty; WOMAC, Western Ontario and McMaster Universities
osteoarthritis index
36
www.annrheumdis.com
METHODS
Patients
An inception cohort of Dutch patients indicated for primary
THA in two general hospitals (Onze Lieve Vrouwe Gasthuis
and Medisch Centrum Alkmaar) and one university hospital
(VU University Medical Centre) was assembled. Selection
criteria were related to the time of placement on the waiting
list rather than the time of surgery. We selected consenting
patients who (a) were scheduled for elective primary THA;
(b) were placed on the hospital waiting list between February
and May 1996; (c) were aged 90 years or younger; (d) had a
diagnosis of primary or secondary OA; (e) were able to
complete a questionnaire; and (f) were living independently.
Finally, the surgeon had to agree that the patient was invited
to participate in the study.
Among the 245 Dutch patients on the waiting list, eight
patients did not receive surgery (either for medical or
personal reasons). In addition, 31 patients were excluded.
Reasons for exclusion were: 2 were older than 90 years; 1 was
not diagnosed with OA; 18 could not complete the
questionnaire (language (5), emotional (2), cognitive (7),
logistic (3, not living in the Netherlands) or other (1)
reasons); 3 were not living in the community; 2 had surgeons
who refused participation; and 5 for other reasons. Of the 206
patients who were eligible, 22 refused or could not be
contacted to request participation, 1 was operated on in
another hospital, and 3 were lost to follow up. The final
Dutch study group comprised 180 patients, corresponding to
a participation rate of 87% of the eligible patients.
For the purpose of studying cross cultural equivalence, data
were used from the study of Jones and colleagues15–18 because
their study design and patient selection criteria were similar
to those of the Dutch study. The Canadian study was a
prospective longitudinal study that followed up a consecutive
community based cohort of patients who were scheduled to
receive a primary THA. Like the Dutch cohort, patients were
enrolled when they were recommended for surgery. Selection
criteria were related to time of placement on the health
regional waiting list. The selection criteria included patients
who (a) were scheduled for elective primary THA; (b) were
placed on the health regional waiting list between December
1995 and January 1997; (c) were placed on the waiting list at
least seven days before their surgery; (d) resided within the
health region; and (e) were English speaking. Patients who
resided in long term care institutions were excluded.
Among the 319 Canadian patients on the waiting list, 29
had their surgery cancelled either for medical reasons or by
personal choice. Of the 290 eligible patients, 32 patients
refused, could not be contacted, or had already had their
surgery, and 14 patients were lost to follow up. The final
Canadian study cohort comprised 244 patients, correspond-
ing to a participation rate of 84% of the eligible patients.
Although no upper age limit was defined, no patients were
90 years or older at the time of surgery. The vast majority of
Canadian patients were diagnosed with primary or secondary
OA.
The study protocol was reviewed and approved by the VU
University Medical Centre Institutional Review Board, Ethics
Committee, and the University of Alberta Health Research
Ethics Board.
Measurements
Sociodemographic characteristics and diagnosis were
extracted from the medical records. Furthermore, all Dutch
patients completed the Dutch WOMAC, the Dutch Arthritis
Impact Measurement Scales (AIMS2), and the Dutch Health
Assessment Questionnaire (HAQ) on the same day, and
within one week before surgery. The questionnaires were self
administered for the Dutch patients. In addition, the Harris
Hip Score (HHS) was administered by interview for the
Dutch patients one or two days before surgery. The Canadian
patients completed the English WOMAC within one month
before surgery. The questionnaire was self administered with
the interviewer assisting when needed for the Canadian
patients.
The WOMAC is well tested, and its reliability, validity, and
responsiveness are satisfactory.6 9 The Dutch translation was
made by two bilingual and bicultural translators, using a
double (back-) translation procedure.5 19 The WOMAC con-
sists of three dimensions: pain (5 items), stiffness (2 items),
and physical functioning (17 items). Because pain and
physical functioning are the major determinants of HR QOL
in patients with OA of the hip, only the pain and physical
functioning dimensions of the WOMAC were studied. The
five point Likert version9 of the WOMAC was used. Item
responses range from ‘‘none’’ to ‘‘extreme’’.
The AIMS2 is a revision of the AIMS,20 a widely used, well
tested, and highly recommended outcome measure for
arthritis research.21 It is expected that this revision of the
AIMS will be the preferred form of the instrument.21 A
validated Dutch version is available.22 The questionnaire
assesses multiple dimensions. We used the arthritis pain
scale (five items) in this study. In addition, we used the
scales dealing with mobility (five items) and walking and
bending (five items), because these scales specifically
measure physical functioning related to the legs. Responses
are based on a Likert scale with five response options ranging
from ‘‘all days’’ to ‘‘no days’’.
The HAQ23 is also a widely used, well tested, and highly
recommended outcome measure for arthritis research.21 Most
published data of the HAQ concern the HAQ Disability Index.
The clinimetric properties of the HAQ discomfort (pain)
dimension are not very clear.21 Pain is measured on a single
15 cm horizontal visual scale with terminal markers
anchored to ‘‘no pain’’ and ‘‘very severe pain’’. The validated
Dutch version of the HAQ24 Disability Index assesses patients’
functional ability, and covers eight fields of activity: dressing,
arising, eating, walking, hygiene, reach, grip, and outside
activities. The Dutch HAQ has 20 items with four response
options ranging from ‘‘independent without difficulty’’ to
‘‘completely dependent’’.
The HHS25 is a widely used, yet poorly tested, outcome
measure for hip arthroplasty research. To our knowledge
there is no official validated Dutch translation of the HHS.
Pain is measured with one item and has six response options.
Function (physical functioning) is measured with seven items,
and has a varying number of response options (two to six).
Sum scores for each scale were calculated after imputing
the corrected item mean in cases of item non-response.26
Furthermore, scale sum scores were standardised (0–100),
with high values indicating less pain or better physical
functioning.
Statistics
Patients
Differences in sociodemographic characteristics between the
Dutch and the Canadian patients were investigated with an
independent samples t test (age) and a x2 test (sex).
Unidimensionality
Unidimensionality indicates that items assess a single
underlying construct.4 In this study unidimensionality was
investigated by principal component analysis.4 In a first
analysis the dimensionality of the pain items was investi-
gated. In a second analysis the dimensionality of the physical
functioning items was investigated.
Unidimensionality was also investigated by Rasch rating
scale analysis,27–29 which relates to the item response theory.
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The Rasch rating scale analysis provides estimates with
standard errors (SEs) of person ability (measures) and item
difficulty (calibrations) along a common measurement
continuum. For instance, the analyses may demonstrate that
a person with unilateral involvement of the hip has a higher
level of ability than another person with bilateral involve-
ment of the hips, and that item A (about walking stairs) is
more difficult than item B (about rising from a chair). The
person measures and item calibrations can be estimated
independently of one another by means of conditional
maximum likelihood. Person measures and item calibrations
are expressed in log-odd units (logits). The logit is a unit of
interval measurement which is defined within the context of
a set of items.30 Unidimensionality of an item set, and also
compliance with the other assumptions of the Rasch model,
is determined by the pattern of item goodness of fit statistics.
The goodness of fit statistics are indices of how well the item
calibration, as estimated for the entire sample, fits the data
with respect to all of the individual subjects in the sample. In
this analysis we report both the infit and the outfit statistic.
The infit statistic focuses on the central performance of an
item. The outfit statistic is an outlier sensitive fit statistic.
Low fit statistics indicate that the item measures redundant
or overlapping content areas. High fit statistics (residual
between observed v predicted score), generally speaking fit
statistics .1.30,31 may indicate that the item is not as closely
related to the overall construct as predicted. Rasch analyses
were performed using BIGSTEPS, version 2.82.30
Reliabili ty
Reliability concerns the degree to which the results of
measurement are consistent across repeated measurements.32
The intratest reliability or internal consistency of the Dutch
WOMAC was quantified by Cronbach’s a. Test-retest
reliability was determined in a subgroup of patients who
had been on the waiting list for longer than one month. This
subgroup consisted of 28 patients who completed the
questionnaire preoperatively twice within 22 days (range 8–
28 days). To estimate the test-retest reliability of the Dutch
WOMAC sum scores, intraclass correlation coefficients
(ICCs) with 95% confidence interval (95% CI) were calcu-
lated, using a two way mixed model. Patients were
considered to be random effects, while the measure effect
was a fixed effect. The ICC is generally considered to be
excellent at 0.75 and above.33
Construct validity
Construct validity is concerned with the extent to which a
particular measure relates to other measures consistent with
theoretically derived hypotheses for the constructs that are
being measured.32 In this study it was suggested that the
standardised sum scores of Dutch WOMAC pain, Dutch
AIMS2 pain, Dutch HAQ pain, and Dutch HHS pain would be
moderately to strongly, r.0.35,34 and positively correlated.
Secondly, it was suggested that the standardised sum scores
of Dutch WOMAC physical functioning, Dutch AIMS2
mobility, Dutch AIMS2 walking and bending, Dutch HAQ
disability, and Dutch HHS function would be moderately to
strongly, and positively correlated. To evaluate the construct
validity of the Dutch WOMAC, Pearson’s correlation coeffi-
cients with 95% CI35 were calculated.
Cross cultural equivalence
Cross cultural equivalence refers to the equivalence of
measurement across different cultural groups of people.5
Equivalence of measurement necessitates a careful transla-
tion process.5 In addition, one can examine the equivalence of
measurement across culture and language by Rasch analyses5
if the data fit the Rasch model. Having a means to determine
item difficulty independently of person abilities enables one
to detect and diagnose DIF.5
According to the recommendations of Cella and collea-
gues,5 the Dutch WOMAC was administered to Dutch
patients and the English WOMAC to Canadian patients.
Owing to the careful translation process none of the Dutch
items were expected to demonstrate DIF caused by the
translation process. Calibration of the items was performed
for the pain scale and the physical functioning scale, and
separately for the Dutch and the English speaking patients.
The calibrated item difficulties resulting from the separate
analysis of each sample for each scale were centred and
plotted against each other, with the Dutch items on the y axis
and the English items on the x axis. An identity line was
drawn through the origin of each plot, with a slope of 1.
Statistical control lines with 95% CI are drawn around the
identity lines to guide interpretation.27 Finally, the plots are
examined to determine whether any items fall outside the
control lines, suggesting DIF.
Corrected sum scores
To make valid comparisons between Dutch and Canadian
patients, sum scores corrected for DIF should be used. The
influence of DIF on a patient’s sum scores can be corrected
when items fit the Rasch model. An important property of the
Rasch model is that, generally speaking, the measurement of
patients is ‘‘test-free’’.27 This means that using different
subsets of the items will result in approximately the same
measure for a patient. Suppose that only item 3 of the five
WOMAC pain items shows DIF. In such a case, the translated
and the original item 3 are handled as two different items:5
item 3D (the translated Dutch item about pain at night), and
item 3E (the original English item about pain at night).
Consequently, item 3 is entered into the dataset as two items
(3D and 3E) with missing data coded on English speaking
patients for the Dutch version (item 3D) and on Dutch
speaking patients for the English versions (item 3E).
Subsequently, the calibrated item difficulties from the
combined analysis of both samples are calculated. The
measurement of the Dutch patients is based on the following
subset of items: items 1, 2, 3D, 4, and 5. The measurement of
the Canadian patients is based on a different subset of items:
items 1, 2, 3E, 4, and 5. Summarising, quantitatively sound
Dutch-English comparisons can be made by creating two
items (3D and 3E) from one item showing DIF (item 3),
anchoring these two items by the calibrations of the other
items not showing DIF (items 1, 2, 4, and 5), and using
different subsets of items for the measurement of the Dutch
and the Canadian patients.
Differences between the Dutch and the Canadian patient
scores for WOMAC pain and physical functioning were
investigated with an independent samples t test, while using
the standardised (0–100) Rasch scores, corrected for DIF,
with high values indicating less pain or better physical
functioning.
RESULTS
Patients
The mean (SD) age of the Dutch patients was 67.9 (10.7)
years. Sixty three (35%) of the Dutch patients were male. The
mean (SD) age of the Canadian patients was 67.4 (11.9)
years and 100 (41%) were male. Differences in age and sex
between the Dutch and the Canadian patients were not
significant (two tailed p = 0.70 and p = 0.21, respectively).
Unidimensionality
In the first principal component analysis the pain items of the
Dutch WOMAC loaded on one component. In the second
analysis the physical functioning items also loaded on one
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component. In Rasch analysis of the Dutch WOMAC (table 1)
the infit statistic for one out of five pain items (pain at night
while in bed) was above 1.30 (1.31), indicating that this item
was not closely related to the underlying construct.31 The SEs
of the pain item calibrations ranged from 0.13 to 0.14 logits,
indicating that the item calibrations were equally well
assessed for the entire range of items. Sixteen of the 17
physical function items fitted the Rasch model (table 1). Both
the infit (1.56) and the outfit (1.51) statistic were greater
than 1.30 for one item (difficulty putting on socks/stockings)
for the Dutch WOMAC. The SE of the item calibration of the
physical functioning items ranged from 0.12 to 0.14 logits.
All pain items of the English WOMAC fitted the model
(table 1); and 16 of the 17 items pertaining to physical
function fitted the Rasch model (table 1). Both the infit
(1.35) and the outfit (1.34) statistic were greater than 1.30
for the item concerning difficulty lying in bed. The SE of the
item calibrations of the pain and physical functioning items
ranged from 0.09 to 0.10 logits.
Reliabili ty
Cronbach’s a for Dutch WOMAC pain was 0.88, and for
Dutch WOMAC physical functioning it was 0.96, indicating
good intratest reliability.4 The ICC (95% CI) for Dutch
WOMAC pain and Dutch WOMAC physical functioning were
0.77 (0.56 to 0.89) and 0.92 (0.83 to 0.96), respectively.
Construct validity
The Pearson correlation coefficient (95% CI) of the Dutch
WOMAC pain (mean (SD) 42.4 (20.5)) standardised sum
score and the Dutch HAQ pain (mean (SD) 35.8 (22.3)) was
0.69 (0.60 to 0.76). A correlation value of 0.39 (0.26 to 0.51)
was seen with the Dutch WOMAC pain and the Dutch HHS
pain (mean (SD) 45.1 (17.3)) standardised sum scores. Dutch
AIMS2 pain was dropped from the analysis owing to a high
mean percentage of item non-response (48%) compared with
the Dutch WOMAC pain (2%) and Dutch HAQ pain (6%). The
correlation between the Dutch WOMAC physical functioning
(mean (SD) 39.6 (18.9)) standardised sum score and the
Dutch AIMS2 mobility standardised score (mean (SD) 69.2
(22.9)) was 0.46 (0.33 to 0.56), while the correlation with the
standardised sum scores of the Dutch AIMS2 walking and
bending (mean (SD) 25.5 (19.7)) was 0.62 (0.52 to 0.70),
with the Dutch HAQ disability (mean (SD) 71.0 (15.5)) it was
0.67 (0.58 to 0.74), and with the Dutch HHS function (mean
(SD) 56.8 (17.4)) it was 0.49 (0.35 to 0.60). All sum scores
were moderately to strongly, and positively correlated,
indicating a satisfactory construct validity.
Cross cultural equivalence
There was DIF for two out of five pain items of the Dutch
WOMAC: item 1 (pain walking on a flat surface) was easier,
and item 3 (pain at night while in bed) was more difficult
than the original English item (fig 1). In addition, there was
DIF for four of the 17 Dutch physical functioning items: item
12 (difficulty bending to floor) and item 22 (difficulty getting
on/off toilet) were easier, whereas item 19 (difficulty lying in
bed) and item 20 (difficulty getting in/out of bath) were more
difficult than the original English items (fig 2).
Corrected sum scores
Table 2 summarises the sum scores for the Dutch and
Canadian patients. The (standardised) corrected Rasch scores
should be used to make valid Dutch-English comparisons.
The mean (SD) standardised corrected Rasch pain score was
45.0 (18.3) for the Dutch patients and 45.6 (14.1) for the
Canadian patients. The mean (SD) standardised corrected
Rasch physical functioning score was 54.0 (16.6) for the
Dutch patients and 53.3 (12.6) for the Canadian patients.
Differences in pain and physical functioning scores between
the Dutch and the Canadian patients were not significant
(two tailed p = 0.70 and p = 0.67, respectively).
DISCUSSION
In this study we demonstrated unidimensionality and, with a
few exceptions, good fit with the Rasch model for the pain
Table 1 Item calibrations with standard error (SE), infit statistics, and outfit statistics for the items of the Dutch WOMAC and
the English WOMAC pain and physical functioning dimensions, according to the item order of the WOMAC
WOMAC
Dutch English
Calibration SE Infit Outfit Calibration SE Infit Outfit
Pain
1. Walking on a flat surface 20.47 0.13 1.10 1.11 20.11 0.10 0.78 0.80
2. Going up or down stairs 21.14 0.14 0.90 0.89 21.19 0.10 0.92 0.91
3. At night while in bed 0.63 0.13 1.31 1.29 0.28 0.10 1.23 1.24
4. Sitting or lying 0.85 0.13 0.73 0.73 1.03 0.10 0.83 0.82
5. Standing upright 0.13 0.13 0.85 0.83 20.01 0.10 1.19 1.18
Physical functioning
8. Descending stairs 0.27 0.12 1.04 1.03 0.19 0.10 0.98 0.97
9. Ascending stairs 20.65 0.12 0.94 0.91 20.58 0.10 0.83 0.84
10. Rising from sitting 0.00 0.12 0.58 0.57 20.01 0.10 0.90 0.92
11. Standing 0.32 0.12 1.16 1.16 0.39 0.10 0.97 0.97
12. Bending to floor 21.09 0.12 1.24 1.21 20.77 0.10 1.02 0.97
13. Walking on flat 0.41 0.12 1.13 1.14 0.33 0.10 0.82 0.81
14. Getting in/out of car 20.91 0.12 0.78 0.77 20.69 0.10 0.67 0.68
15. Going shopping 20.87 0.12 0.91 0.88 20.90 0.10 0.80 0.77
16. Putting on socks/stockings 20.82 0.12 1.56 1.51 20.94 0.10 1.29 1.27
17. Rising from bed 0.56 0.12 0.71 0.70 0.59 0.10 0.76 0.76
18. Taking off socks/stockings 20.14 0.12 1.20 1.18 20.17 0.10 1.17 1.18
19. Lying in bed 1.29 0.12 1.23 1.21 0.99 0.09 1.35 1.34
20. Getting in/out of bath 0.28 0.14 1.10 1.11 20.20 0.10 1.16 1.24
21. Sitting 1.54 0.12 1.00 0.96 1.56 0.09 0.96 0.98
22. Getting on/off toilet 0.51 0.12 0.68 0.67 1.03 0.09 1.11 1.09
23. Heavy domestic duties 21.56 0.13 0.85 0.87 21.72 0.10 1.11 1.06
24. Light domestic duties 0.86 0.12 0.73 0.73 0.90 0.09 1.04 1.02
Calibrations are expressed in logits. Negative calibrations indicate easier items; positive calibrations indicate more difficult items.
Infit and outfit statistics .1.30 indicate items that do not contribute to the underlying construct. Statistics .1.30 are shown in italics. Infit and outfit statistics ,0.70
indicate items that are muted.
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and physical functioning items of the Likert version of the
Dutch WOMAC, and the Likert version of the English
WOMAC. Good fit with the Rasch model was demonstrated
in patients with hip OA scheduled for elective primary THA,
who are patients with severe OA. An important property of
the Rasch model is that the item calibrations are ‘‘sample-
free’’.27 This implies that, generally speaking, the use of
patient groups with less pain or limitations in physical
functioning, such as patients with mild OA, will result in
similar item calibrations. In addition, the precision of the
assessment of the item calibrations is calculated, and
expressed as an SE. In this study, the SE of the item
calibrations within one dimension, were similar, which
indicates that all item calibrations were equally well assessed.
So the inclusion of only patients with severe OA does not
seem to have a major impact on the precision of the
assessment of the item calibrations, or consequently on the
presence of DIF.
Good fit of the WOMAC items with the Rasch model was
also demonstrated in other studies. Wolfe and Kong
demonstrated good fit with the Rasch model for the visual
analogue scale version (converted to an 11 point Likert scale)
of the English WOMAC in patients with knee OA (n = 655),
including patients with mild OA.8 They found misfit for two
physical functioning items (item 8: difficulty descending
stairs, and item 20: difficulty getting in/out of bath). Ryser
and colleagues demonstrated good fit with the Rasch model
for an 11 point Likert version of the German WOMAC in
patients with hip and knee OA (n = 158).36 A misfit for one
item (item 3: pain at night while in bed) was reported, which
was also the only misfitting pain item in the Dutch WOMAC.
An explanation for the misfit of item 3 may be that the pain
is nocturnal rather than daytime pain. Rojkovich and Gibson
demonstrated in patients with rheumatoid arthritis that
nocturnal pain scores correlated best with measures of joint
inflammation, whereas daytime pain scores, both at rest and
on movement, seemed to be influenced by the degree of
permanent joint damage.37 In summary, a good fit with the
Rasch model was demonstrated for different translations and
different versions of the WOMAC, in different patients
Table 2 Mean with SD WOMAC sum scores for the Dutch and Canadian patients
WOMAC
Dutch Canadian
Mean SD Mean SD
Pain
Raw sum score 16.5 4.1 16.4 3.2
Standardised raw sum score 42.4 20.5 43.0 15.9
Corrected Rasch score 0.7 2.3 0.7 1.7
Standardised and corrected Rasch score 45.0 18.3 45.6 14.1
Physical functioning
Raw sum score 58.1 12.9 58.9 10.1
Standardised raw sum score 39.6 18.9 38.4 14.9
Corrected Rasch score 0.9 1.8 1.0 1.4
Standardised and corrected Rasch score 54.0 16.6 53.3 12.6
Raw sum scores, with lower scores indicating less pain (range 5–25) or better physical functioning (range 17–85).
Standardised raw sum scores (range 0–100), with higher scores indicating less pain or better physical functioning.
Corrected Rasch scores, with lower scores indicating less pain (range 26.04–6.26) or better physical functioning
(range 24.18–6.82).
Standardised and corrected Rasch scores (range 0–100), with higher scores indicating less pain or better physical
functioning.
Figure 1 Pain item calibrations for the Dutch WOMAC and the English
WOMAC. English calibrations on the x axis, and Dutch on the y axis.
Calibrations are expressed in logits. Negative calibrations indicate
easier items. Positive calibrations indicate more difficult items. An
identity line is drawn through the origin, with a slope of 1. Statistical
control lines (95% CI) are drawn around the identity line (dotted lines).
The area between the dotted lines depicts acceptable item deviation.
Items outside the control lines demonstrate DIF. The numbers near the
data points refer to the WOMAC item numbers. For a full explanation of
the items see table 1.
Figure 2 Physical functioning item calibrations for the Dutch WOMAC
and the English WOMAC. English calibrations on the x axis, and Dutch
on the y axis. Calibrations are expressed in logits. Negative calibrations
indicate easier items. Positive calibrations indicate more difficult items.
An identity line is drawn through the origin, with a slope of 1. Statistical
control lines (95% CI) are drawn around the identity line (dotted lines).
The area between the dotted lines depicts acceptable item deviation.
Items outside the control lines demonstrate DIF. The numbers near the
data points refer to the WOMAC item numbers. For a full explanation of
the items see table 1.
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groups, and with different severities of OA. Good fit with the
Rasch model offers excellent opportunities to study the cross
cultural equivalence of translations of the WOMAC by
assessing DIF.
The testing of reliability and construct validity showed
satisfactory results. The high percentage of item non-
response for the AIMS pain scale was unexpected. We believe
that this was because the instructions for patients stated that
the questions were about ‘‘rheumatoid pain’’. Most patients
waiting for THA in the Netherlands are well aware of the fact
that they have OA, and not rheumatoid arthritis. Respon-
siveness or sensitivity to change38 of the Dutch WOMAC was
not examined in this paper. This clinimetric aspect of the
Dutch WOMAC should be addressed in further research. The
responsiveness of a translated measurement instrument, just
like dimensionality, reliability, and construct validity, does
not prove that valid cross cultural comparisons can be made.
Moreover, comparable responsiveness of the original and the
translated instrument does not address the validity of cross
cultural comparisons. For instance, if the sum scores both
preoperatively and postoperatively are higher on the original
than on the translated instrument owing to DIF, then the
change in score on the original and translated instruments,
and the responsiveness of both instruments may be the same,
despite a lack of comparability of the scores on the original
and translated instruments.
We found DIF for six of the 22 items, which does not
automatically indicate inaccurately translated items. There
are many other reasons for DIF, apart from a poor
translation. Firstly, DIF may be due to chance, and this
may be demonstrated when the study is replicated. When a
study has been replicated several times, and DIF for a certain
item was found in only one of these studies, chance seems to
be a reasonable explanation for the DIF. In this study one
might expect that DIF of one or two items is due to chance. It
is, however, very unlikely that the DIF of six out of 22 items is
due to chance. Secondly, large sample sizes will introduce
DIF, because small irrelevant differences in item calibrations
will become statistically significant differences. In our
opinion, about 400 patients, evenly divided between two
groups, is a reasonable sample size. Thirdly, DIF can reflect
real differences between different cultural and language
settings. For instance, the standard seat height for chairs in
the Netherlands is higher than the standard height in
Canada. Therefore, rising from a chair should be easier
in the Netherlands. Fourthly, one may argue that the DIF can
also be caused by differences in age, sex, or disease
characteristics between the Dutch and Canadian groups.
For example, men have more difficulty getting on/off the
toilet, due to their longer legs, which makes the seat ‘‘lower’’
for them. Therefore, a difference in sex ratio between the two
comparison groups will induce DIF. In this study, the
differences in age and sex ratios were very small, and not
statistically significant, and differences in disease character-
istics were minimised by including only patients with OA
waiting for primary THA. Lastly, DIF can be caused by
different administration modes. In this study, different
administration modes were used for the Dutch (self
administered) and the Canadian patients (self administered
with interviewer assistance). Cella et al argue that in studies
that compare self administered data with interview adminis-
tered data little difference is found in the responses given.5
This still remains a point of concern in our study.
DIF can indicate an incorrect translation of an item,
including an incorrect translation of the answer categories.
An incorrect translation (for example, the activity in the
Dutch translation has become a more comprehensive, thus
a more difficult activity, than in the original English
translation) will result in DIF. We resubmitted the six
malfunctioning items to three native English speakers who
had been living in the Netherlands for at least 10 years. They
suggested that the translation of items 1, 12, and 19 could be
improved. These three items will be rephrased, and will
therefore have to be tested in further research.
For an item showing DIF after translation, the translation
should be improved, or corrections should be made for the
differences in item difficulty. In this study, DIF was corrected
in order to make quantitatively sound Dutch-English
comparisons. The (standardised) corrected Rasch pain and
physical functioning scores of the Dutch and Canadian
patients were remarkably comparable. This might indicate
that the method of selecting patients for THA in the
Netherlands and Canada is quite similar.
Despite satisfactory dimensionality, reliability, and con-
struct validity, our study showed that DIF was found for
some items of the Dutch WOMAC. In addition, our study
demonstrated that the Dutch WOMAC permits valid Dutch-
English comparisons after correction for DIF.
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